From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

NFT Investments – this all stinks like a rotting kipper and will be seen as unacceptable bull market greed: first investment made

By Tom Winnifrith | Monday 26 April 2021


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


David Lenigas was unable to float his poxy related party spoof Lenigas Cuba on AIM or the Standard List as regulators objected to the way he awarded himself gazillions of founder shares at peanuts before raising money shortly after from mug punters at a vast premium.  There was no justification for the uplift, it was just greed, and even the AIM sewer and the FCA regulated (no sniggering at the back) Standard List have some standards. Luckily, Aquis has no standards and so Lenigas Cuba listed there. Of course it ended in tears. But that established that Aquis has no qualms about quite appalling greed. Take NFT Investments.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:27:55